p62 as an oncotarget mediates cisplatin resistance through RIP1-NF-KappaB pathway in human ovarian cancer cells

Yan, XY; Zhang, Y; Zhang, JJ; Zhang, LC; Liu, YN; Wu, Y; Xue, YN; Lu, SY; Su, J; Sun, LK

CANCER SCIENCE, 2018; 109 (): 1217